News | April 14, 2026
NASA’s Artemis II mission to on board Opella’s Dulcolax for lunar orbit mission
A brand from Opella will be part of the official NASA astronaut formulary
A brand from Opella will be part of the official NASA astronaut formulary
The new test offers a minimally invasive blood-based approach to tracking neurological damage, measuring neurofilament light chain
With the expansion, the hospital’s total bed capacity will rise from 380 to 539 beds
Highlights Mirvetuximab-based regimen promise
The centre offers a full spectrum of FDA-approved services, including physiotherapy, occupational therapy, speech and language therapy, and aqua therapy
The campaign builds on the three-year partnership unveiled earlier this season
Spread across nearly 4,500 sq. ft., the new clinic combines advanced dental technology, experienced specialists, and an Atithi-first care model
The license is valid for five years, effective from April 9, 2026
At the centre of this shift is Eli Lilly and Company, whose latest investments in China and Japan are helping redefine the next phase of GLP-1 supply strategy
MoU aims to strengthen academia-industry collaboration in healthcare research and innovation
Subscribe To Our Newsletter & Stay Updated
